PMV Pharmaceuticals (PMVP) Institutional Ownership $1.55 +0.06 (+4.03%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$1.58 +0.03 (+1.94%) As of 09/3/2025 06:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for PMV Pharmaceuticals (NASDAQ:PMVP)CurrentInstitutional OwnershipPercentage90.20%Number ofInstitutional Buyers(last 12 months)20TotalInstitutional Inflows(last 12 months)$11.06MNumber ofInstitutional Sellers(last 12 months)21TotalInstitutional Outflows(last 12 months)$3.91M Get PMVP Insider Trade Alerts Want to know when executives and insiders are buying or selling PMV Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data PMVP Institutional Buying and Selling by Quarter PMV Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Shay Capital LLC24,310$26K0.0%N/A0.046% 8/13/2025 Walleye Capital LLC77,887$83K0.0%-23.4%0.147% 8/13/2025 Stonepine Capital Management LLC845,968$897K0.9%+34.2%1.596% 8/11/2025 BML Capital Management LLC5,000,000$5.30M4.0%+33.4%9.624% 8/7/2025 Acadian Asset Management LLC2,066,137$2.19M0.0%+0.9%3.977% 7/31/2025 Peapod Lane Capital LLC452,682$480K0.5%-7.5%0.871% 7/11/2025 Assenagon Asset Management S.A.263,059$279K0.0%+128.7%0.506% 6/27/2025 Goldman Sachs Group Inc.90,263$98K0.0%-25.6%0.174% 5/21/2025 Acadian Asset Management LLC2,047,177$2.23M0.0%-1.5%3.940% 5/16/2025 Goldman Sachs Group Inc.90,263$98K0.0%-25.6%0.174% Get the Latest News and Ratings for PMVP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PMV Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/16/2025 Jacobs Levy Equity Management Inc.129,914$142K0.0%-75.9%0.250% 5/14/2025 Stonepine Capital Management LLC630,183$687K0.7%+17.6%1.213% 5/14/2025 Walleye Capital LLC101,696$111K0.0%-20.3%0.196% 5/13/2025 Aldebaran Capital LLC523,553$571K0.5%+4.3%1.008% 5/12/2025 Connor Clark & Lunn Investment Management Ltd.267,636$292K0.0%-27.8%0.515% 5/7/2025 BML Capital Management LLC3,747,612$4.09M3.1%+8.1%7.214% 4/30/2025 Peapod Lane Capital LLC489,370$533K0.6%+9.8%0.942% 4/15/2025 Assenagon Asset Management S.A.115,038$125K0.0%-25.2%0.222% 2/17/2025 Velan Capital Investment Management LP35,000$53K0.0%N/A0.068% 2/17/2025 Squarepoint Ops LLC73,015$110K0.0%+68.7%0.141% 2/17/2025 Two Sigma Investments LP506,986$766K0.0%+5.0%0.980% 2/17/2025 Two Sigma Advisers LP714,600$1.08M0.0%-4.9%1.381% 2/17/2025 Stonepine Capital Management LLC535,805$809K0.7%N/A1.035% 2/17/2025 Shay Capital LLC156,451$236K0.0%-16.8%0.302% 2/17/2025 Millennium Management LLC318,020$480K0.0%-12.6%0.615% 2/17/2025 Jacobs Levy Equity Management Inc.539,893$815K0.0%-23.5%1.043% 2/17/2025 D. E. Shaw & Co. Inc.1,024,288$1.55M0.0%-1.6%1.979% 2/17/2025 Bridgeway Capital Management LLC202,100$305K0.0%+44.5%0.391% 2/17/2025 Bank of America Corp DE44,568$67K0.0%-63.1%0.086% 2/17/2025 Ameriprise Financial Inc.22,807$34K0.0%-42.3%0.044% 2/17/2025 ArrowMark Colorado Holdings LLC3,508,451$5.30M0.1%-3.8%6.780% 2/14/2025 Jane Street Group LLC49,870$75K0.0%-32.7%0.096% 2/14/2025 Schonfeld Strategic Advisors LLC35,200$53K0.0%-47.4%0.068% 2/14/2025 Northern Trust Corp107,340$162K0.0%+23.2%0.207% 2/14/2025 RBF Capital LLC245,561$380K0.0%-3.1%0.475% 2/13/2025 Walleye Capital LLC127,626$193K0.0%-12.4%0.247% 2/12/2025 Aldebaran Capital LLC502,190$758K0.7%+14.6%0.970% 2/12/2025 Geode Capital Management LLC421,710$637K0.0%-2.6%0.815% 2/12/2025 JPMorgan Chase & Co.24,591$37K0.0%+2,282.8%0.048% 2/10/2025 Connor Clark & Lunn Investment Management Ltd.370,920$560K0.0%-15.9%0.717% Retire Comfortably with These New Monthly Income ETFs? (Ad)Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns just aren’t enough anymore. But what if you could reach your Freedom Number—the monthly income that makes retirement secure—using far less money than you thought possible? That’s exactly what Kelly G. discovered. She calls it “life-changing,” saying the income just keeps growing and that early retirement suddenly looks real. This strategy was once reserved for the ultra-wealthy, but it’s now available to everyday investors.Click here to watch the free presentation and learn how to calculate your personal Freedom Number—an2/7/2025 BML Capital Management LLC3,466,684$5.24M3.3%+105.3%6.699% 1/29/2025 Peapod Lane Capital LLC445,744$673K0.7%N/A0.861% 1/14/2025 Assenagon Asset Management S.A.153,701$232K0.0%-56.6%0.297% 11/20/2024 Virtu Financial LLC28,146$42K0.0%N/A0.054% 11/19/2024 Barclays PLC30,248$45K0.0%-93.5%0.058% 11/15/2024 M&T Bank Corp399,548$596K0.0%+54.6%0.772% 11/15/2024 Barclays PLC30,248$45K0.0%-93.5%0.058% 11/15/2024 XTX Topco Ltd24,160$36K0.0%-83.6%0.047% 11/15/2024 Jane Street Group LLC74,089$110K0.0%-54.8%0.143% 11/15/2024 Jacobs Levy Equity Management Inc.705,593$1.05M0.0%-9.4%1.364% 11/15/2024 ArrowMark Colorado Holdings LLC3,647,291$5.43M0.1%+30.0%7.048% 11/15/2024 Point72 Asia Singapore Pte. Ltd.32,190$48K0.0%-48.6%0.062% 11/14/2024 PFM Health Sciences LP2,011,040$3.00M0.2%+57.7%3.886% 11/14/2024 Sio Capital Management LLC3,214,239$4.79M1.9%+18.7%6.211% 11/5/2024 BML Capital Management LLC1,688,772$2.52M1.5%+29.0%3.278% 10/23/2024 Assenagon Asset Management S.A.353,837$527K0.0%+36.1%0.687% 9/16/2024 Cubist Systematic Strategies LLC69,867$113K0.0%+570.8%0.136% 9/16/2024 Point72 Asia Singapore Pte. Ltd.62,634$101K0.0%N/A0.122% 8/15/2024 Point72 Asia Singapore Pte. Ltd.62,634$101K0.0%N/A0.122% 8/14/2024 Cubist Systematic Strategies LLC69,867$113K0.0%+570.8%0.136% 8/14/2024 Evoke Wealth LLC63,233$102K0.1%N/A0.123% 8/12/2024 XTX Topco Ltd147,542$239K0.0%-24.3%0.287% 8/9/2024 Dimensional Fund Advisors LP126,004$204K0.0%-53.8%0.245% 8/1/2024 Rhumbline Advisers23,035$37K0.0%-63.3%0.045% 7/18/2024 Assenagon Asset Management S.A.260,028$421K0.0%+267.2%0.505% 5/29/2024 Opaleye Management Inc.471,481$802K0.2%N/A0.917% 5/16/2024 Jacobs Levy Equity Management Inc.826,704$1.41M0.0%+92.4%1.607% 5/15/2024 Public Employees Retirement System of Ohio22,757$39K0.0%+174.2%0.044% 5/15/2024 Price T Rowe Associates Inc. MD42,802$73K0.0%+71.6%0.083% 5/10/2024 Acadian Asset Management LLC2,080,194$3.53M0.0%+170.7%4.044% 5/10/2024 Vanguard Group Inc.2,452,111$4.17M0.0%+1.9%4.767% 5/7/2024 Marquette Asset Management LLC64,009$109K0.0%N/A0.124% 5/1/2024 Mirae Asset Global Investments Co. Ltd.15,492$26K0.0%N/A0.030% 4/23/2024 Fishman Jay A Ltd. MI80,000$136K0.0%+166.7%0.156% 4/23/2024 BML Capital Management LLC1,306,490$2.22M1.5%N/A2.540% 2/15/2024 PFM Health Sciences LP1,473,013$4.57M0.3%+13.7%2.879% 2/14/2024 Personal CFO Solutions LLC550,342$1.71M0.3%+57.1%1.076% 2/14/2024 Sectoral Asset Management Inc.685,985$2.13M0.9%+125.8%1.341% 2/13/2024 Aristides Capital LLC31,145$97K0.0%N/A0.061% 2/13/2024 Tower Research Capital LLC TRC9,508$29K0.0%+344.3%0.019% 2/8/2024 Independent Advisor Alliance12,500$39K0.0%N/A0.024% 2/6/2024 M&T Bank Corp197,682$612K0.0%N/A0.386% 1/31/2024 Federated Hermes Inc.703,338$2.18M0.0%-10.2%1.375% 1/30/2024 Vontobel Holding Ltd.685,985$2.13M0.0%+125.8%1.341% 1/17/2024 Assenagon Asset Management S.A.70,814$220K0.0%-72.6%0.138% 1/12/2024 SG Americas Securities LLC20,994$65K0.0%N/A0.041% 12/1/2023 Euclidean Capital LLC2,627,643$16.13M3.5%+3.2%5.136% 12/1/2023 Wellington Management Group LLP542,883$3.33M0.0%-4.1%1.061% 11/15/2023 RTW Investments LP2,375,785$14.59M0.3%-21.6%4.644% 11/15/2023 Sectoral Asset Management Inc.303,824$1.87M0.4%-8.6%0.594% Retire Comfortably with These New Monthly Income ETFs? (Ad)Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns just aren’t enough anymore. But what if you could reach your Freedom Number—the monthly income that makes retirement secure—using far less money than you thought possible? That’s exactly what Kelly G. discovered. She calls it “life-changing,” saying the income just keeps growing and that early retirement suddenly looks real. This strategy was once reserved for the ultra-wealthy, but it’s now available to everyday investors.Click here to watch the free presentation and learn how to calculate your personal Freedom Number—an11/15/2023 Alkeon Capital Management LLC2,347,414$14.41M0.0%+58.6%4.588% 11/14/2023 Trexquant Investment LP68,202$419K0.0%N/A0.133% 11/14/2023PEAK6 Investments LLC32,500$200K0.0%N/A0.064% 11/13/2023 Connor Clark & Lunn Investment Management Ltd.169,699$1.04M0.0%+3.5%0.332% 11/13/2023 Algert Global LLC27,790$171K0.0%N/A0.054% 11/13/2023 Federated Hermes Inc.783,539$4.81M0.0%-6.8%1.532% 11/13/2023 Hsbc Holdings PLC30,679$184K0.0%-21.4%0.060% 11/9/2023 Citigroup Inc.365,564$2.25M0.0%+468.4%0.754% 11/8/2023 New York Life Investment Management LLC74,525$458K0.0%-13.7%0.154% 11/7/2023 Barclays PLC471,012$2.89M0.0%+96.0%0.972% (Data available from 1/1/2016 forward) PMVP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PMVP shares? During the previous two years, 65 institutional investors and hedge funds held shares of PMV Pharmaceuticals. The most heavily invested institutionals were Euclidean Capital LLC ($16.13M), RTW Investments LP ($14.59M), Alkeon Capital Management LLC ($14.41M), Principal Financial Group Inc. ($5.64M), BML Capital Management LLC ($5.30M), ArrowMark Colorado Holdings LLC ($5.30M), and Sio Capital Management LLC ($4.79M).Learn more on PMV Pharmaceuticals' institutional investors. What percentage of PMV Pharmaceuticals' stock is owned by institutional investors? 90.20% of PMV Pharmaceuticals' stock is owned by institutional investors. Learn more on PMVP's institutional investor holdings. Which institutional investors have been buying PMV Pharmaceuticals' stock? Of the 44 institutional investors that purchased PMV Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($5.00M), Acadian Asset Management LLC ($1.33M), PFM Health Sciences LP ($913.49K), Alkeon Capital Management LLC ($867.55K), Stonepine Capital Management LLC ($845.97K), ArrowMark Colorado Holdings LLC ($842.51K), and Sio Capital Management LLC ($505.83K). How much institutional buying is happening at PMV Pharmaceuticals? Institutional investors have bought a total of 7,966,158 shares in the last 24 months. This purchase volume represents approximately $11.06M in transactions. Which of PMV Pharmaceuticals' major shareholders have been selling company stock? Of the 21 institutional investors that sold PMV Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Barclays PLC ($869.41K), Jacobs Levy Equity Management Inc. ($649.11K), Assenagon Asset Management S.A. ($238.80K), Connor Clark & Lunn Investment Management Ltd. ($173.39K), ArrowMark Colorado Holdings LLC ($138.84K), XTX Topco Ltd ($123.38K), and Jane Street Group LLC ($114.18K). How much institutional selling is happening at PMV Pharmaceuticals? Institutional investors have sold a total of 2,809,546 shares in the last 24 months. This volume of shares sold represents approximately $3.91M in transactions. Related Companies Monte Rosa Therapeutics Major Shareholders DiaMedica Therapeutics Major Shareholders scPharmaceuticals Major Shareholders Contineum Therapeutics Major Shareholders 4D Molecular Therapeutics Major Shareholders Capricor Therapeutics Major Shareholders Foghorn Therapeutics Major Shareholders Lifecore Biomedical Major Shareholders Tvardi Therapeutics Major Shareholders Neumora Therapeutics Major Shareholders This page (NASDAQ:PMVP) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PMV Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PMV Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.